Your browser doesn't support javascript.
loading
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells.
Bulstrode, Harry; Girdler, Gemma C; Gracia, Tannia; Aivazidis, Alexander; Moutsopoulos, Ilias; Young, Adam M H; Hancock, John; He, Xiaoling; Ridley, Katherine; Xu, Zhaoyang; Stockley, John H; Finlay, John; Hallou, Clement; Fajardo, Teodoro; Fountain, Daniel M; van Dongen, Stijn; Joannides, Alexis; Morris, Robert; Mair, Richard; Watts, Colin; Santarius, Thomas; Price, Stephen J; Hutchinson, Peter J A; Hodson, Emma J; Pollard, Steven M; Mohorianu, Irina; Barker, Roger A; Sweeney, Trevor R; Bayraktar, Omer; Gergely, Fanni; Rowitch, David H.
Afiliación
  • Bulstrode H; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: hb252@cam.ac.uk.
  • Girdler GC; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Gracia T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
  • Aivazidis A; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Moutsopoulos I; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
  • Young AMH; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Hancock J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
  • He X; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
  • Ridley K; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Xu Z; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Stockley JH; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Finlay J; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Hallou C; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Fajardo T; Department of Virology, University of Cambridge, Cambridge CB2 0QQ, UK; Department of Virology, Royal London Hospital, Barts Health NHS Trust, London E1 2ES, UK.
  • Fountain DM; Manchester Centre for Clinical Neurosciences, Manchester M6 8HD, UK.
  • van Dongen S; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Joannides A; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Morris R; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Mair R; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Watts C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2SY, UK.
  • Santarius T; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Price SJ; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Hutchinson PJA; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Hodson EJ; Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Pollard SM; Centre for Regenerative Medicine and Cancer Research UK Edinburgh Centre, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.
  • Mohorianu I; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
  • Barker RA; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
  • Sweeney TR; Department of Virology, University of Cambridge, Cambridge CB2 0QQ, UK; The Pirbright Institute, Guildford, Surrey GU24 0NF, UK.
  • Bayraktar O; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
  • Gergely F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK. Electronic address: fanni.gergely@bioch.ox.ac.uk.
  • Rowitch DH; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Wellcome Sanger Institute, Hinxton CB10 1SA, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: dhr25@medschl.cam.ac.uk.
Neuron ; 110(23): 3936-3951.e10, 2022 12 07.
Article en En | MEDLINE | ID: mdl-36174572
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Zika / Infección por el Virus Zika Límite: Humans Idioma: En Revista: Neuron Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Zika / Infección por el Virus Zika Límite: Humans Idioma: En Revista: Neuron Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article